The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, Black people need ...

Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...